Votrient Approved for Advanced Kidney Cancer (HealthDay)
Y! Health News Search RSS Feed by Tue, 20 Oct 2009 09:03:41 PDT.
HealthDay - TUESDAY, Oct. 20 (HealthDay News) -- Votrient (pazopanib) has been approved to treat advanced renal cell carcinoma, a form of kidney cancer in which cancerous cells invade the lining of small tubes in the kidney called tubules, the U.S. Food and Drug Administration said in a news release.
